Minnebio CEO Dr. David Liang Attended the 2024 ADLM Exhibition in Chicago

Dr. David Liang, recently attended the 2024 ADLM (Association for Diagnostics & Laboratory Medicine) Exhibition in Chicago. Formerly known as AACC, the ADLM Exhibition stands as a leading global event for laboratory professionals, researchers, and industry pioneers, showcasing cutting-edge advancements in clinical diagnostics, laboratory technology, and medical innovation.

Drawing participants from across healthcare, diagnostics, biotechnology, and academic research sectors, the exhibition serves as a vital platform for thought leadership, networking, and collaborative exploration.

Dr. Liang’s participation at ADLM underscores Minnebio’s commitment to advancing laboratory medicine through innovative solutions designed for diagnostic applications and drug development. Leveraging our expertise in various bioreagents and cell culture media, Minnebio is dedicated to contributing to transformative developments in clinical diagnostics and precision medicine.

We are inspired by the knowledge and relationships cultivated during the event and remain focused on forging impactful partnerships to drive progress in laboratory medicine and biotechnology. Minnebio continues its mission to enhance the global diagnostic landscape through innovation and collaboration.

SHARE

Related Post

Expanding the Therapeutic Frontier with Bispecific Antibodies

Bispecific antibodies (bsAbs) provide novel mechanisms of action and therapeutic possibilities beyond...

YAP-Mediated Therapy Resistance in NSCLC Depends on Tumor Architecture

This study in eLife highlights that YAP, a protein linked to cancer...

Leptomeningeal Metastasis and IFNγ-Mediated Immune Response as a Therapeutic Target

Leptomeningeal metastasis—a deadly spread of solid tumors to the cerebrospinal-fluid-filled membranes around...